Nara Health raises $14M for AI-native health-insurance administration

Chicago healthtech Nara Health said it raised $14 million across pre-seed and seed rounds led by Khosla Ventures, with Long Journey Ventures, Superior Studios, and other angels participating, positioning itself as an AI-native third-party administrator (TPA) for employer health plans — one platform for benefits administration, claims processing, care orchestration, and member support — and said it has more than 25,000 members and has processed more than $600 million in claims.

The shop that pays your work-health claim and picks up the phone is usually a TPA — a back-office, not the logo on your insurance card. Nara says it is turning that shop into one AI platform. The $14 million and the member counts are the company’s.

Nara Health said via Business Wire on 14 Sep 2026 at 09:00 ET that it had raised $14 million in total funding across a pre-seed and a seed round. That company release, carried on Financial Content, is the filing event. FinSMEs’ same-day wrap calls the company a Chicago healthtech and notes it was formerly Avant Health. These are company and trade-press lines. This desk did not see a separate close statement.

Khosla Ventures led the rounds, the company said, with Long Journey Ventures, Superior Studios, and other investors and angels participating. File the names as Nara’s list. This desk is not saying a valuation was disclosed. It was not.

Nara positions itself as an AI-native third-party administrator, or TPA. A TPA, in plain English, is the back-office that runs an employer’s self-funded or custom health plan — paying claims, keeping the benefits rules, handling prior authorization, and answering member questions. Prior authorization is the plan’s yes before a procedure or drug is covered. File the TPA pitch as the company’s.

The company said one platform now combines benefits administration, claims processing, care orchestration, and member support. Care orchestration, as Nara uses it, means steering a member to the right clinic or specialist. It also names alternative plan designs — direct provider contracts, cash pay, reference-based pricing, and direct primary care — as ways to price care outside the usual hospital-billed insurance path. File those designs as company product talk, not as savings this desk measured.

Company traction claims, all Nara’s and not desk-verified: more than 25,000 members; more than $600 million in claims processed; member calls answered in an average of 5 seconds; same-day prior-authorization turnaround versus a 3-to-5-day industry standard. File the counts and the speed lines as the company said them. This desk did not audit membership, claims dollars, call logs, or prior-auth clocks.

Sidhartha Sinha, co-founder and CEO, said Nara was born to solve coverage and care together, and that bringing benefits administration, claims, care orchestration, and member support onto one platform helps employers cut costs while making benefits easier to use. File the quote as his, via the company release.

Samir Kaul, founding partner and managing director at Khosla Ventures, said employer plans have absorbed decades of cost increases with no real way to push back on pricing, and that Sinha’s team has both the clinical and technical depth to rebuild how those dollars are spent. File the quote as his.

Matt Brow, CEO of Advanced Medical Pricing Solutions (AMPS), said his firm wanted a tech-forward TPA, jumped to self-insurance after a 27% renewal increase on a level-funded plan, and that eight months in, benefits costs were down 55% year over year while members got a better experience. Self-insurance here means the employer pays medical bills from its own pot, with a TPA running the paperwork. File the 27% and 55% as Brow’s customer claim, via the company release — not as a result this desk checked.

FinSMEs said the company intends to use the funds to expand its AI-native member experience, scale care orchestration, and speed adoption of personalized — alternative — health plans for employers. File the use of proceeds as FinSMEs’ wrap of the company plan.

CONFIRMED here: Nara’s 14 Sep 2026 Business Wire release at 09:00 ET, via Financial Content — PRIMARY company source. FinSMEs is a same-day C press wrap, not a second originating newsroom. NOT claimed: a valuation, independently verified member or claims figures, that this desk timed the five-second call or the same-day prior auth, FDA clearance, a stock tip, or investment advice. Distinct from the already-filed tandem-health-100m-series-b, oracle-health-clinical-ai-agent-nurses, ataraxis-tau-chemo, and beta-bionics-mint-fda.